SAPPHIRE Registry
» Principal Investigator: Marc Schermerhorn, MD
» Coordinator: Mary Trovato, RN, BSN
Why is this study being done?
This study is being done to collect data regarding patients’ medical experiences and conditions following treatment of carotid artery stenosis (narrowing in the artery in the neck) with the PRECISE Nitinol Stent Systems and the ANGIOGUARD XP/RX Emboli Capture Guidewire. These devices have received FDA approval/clearance for commercial use. This means that the devices are not investigational.
Who will participate in this study?
Approximately 25 people will take part in this study at Beth Israel Deaconess Medical Center. A total of 15,000 people will take part in this study at all study sites.
